GTG
Click for more information
16.3% 3.6¢ genetic technologies limited

Myriad could seek to acquire Genetic Technologies

  1. haresh4421
    16 Posts.
    clock Created with Sketch.
    29/11/15
    21:44
    Post #: 16505260
    Myriad Genetic is a molecular diagnostic company with 2.5B market cap that offer testing for two high risk breast cancer genes, BRACA1 and BRACA2. IMO DYOR Flight is going to take off.
    GTG Price at posting: 3.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
3.6¢ 		Change
-0.007(16.3%) 		Mkt cap ! $5.235M
Open High Low Value Volume
4.0¢ 4.0¢ 3.6¢ $1.352K 35.73K

Buyers (Bids)

No. Vol. Price($)
1 55500 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 114500 1
View Market Depth
Last trade - 10.41am 08/08/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.